Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About Us
    • AACR Journals
    • Subscriptions
    • Permissions & Reprints
    • Advertising
  • Article Collections
    • Focus Sections
    • Journal Collections
    • Hot Topics
    • "Best of" Collection
    • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Researchers Behind the Journals: Researcher Profiles
  • Alerts
    • Table of Contents
    • Editors' Picks
  • COVID-19
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Association for Cancer Research

American Association for Cancer Research

Advanced Search

  • Home
  • About Us
    • AACR Journals
    • Subscriptions
    • Permissions & Reprints
    • Advertising
  • Article Collections
    • Focus Sections
    • Journal Collections
    • Hot Topics
    • "Best of" Collection
    • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Researchers Behind the Journals: Researcher Profiles
  • Alerts
    • Table of Contents
    • Editors' Picks
  • COVID-19
  • Visit AACR on Facebook
  • Follow AACR on Twitter
  • Visit AACR on LinkedIn
  • Visit AACR on YouTube

COVID-19 & Cancer

COVID-19 & Cancer

COVID-19 & Cancer

The AACR appreciates that the COVID-19 pandemic might well be impacting your health, the work ongoing in your labs, and may be placing you on the front lines to fight and care for those affected. In support of your research, particularly as it relates to COVID-19, the AACR has undertaken a number of initiatives, including the creation of a COVID-19 Task Force, the hosting of special sessions on COVID-19 and cancer at the recent AACR Virtual Annual Meetings, a special virtual conference that focused on COVID-19 and cancer, and this COVID-19 & Cancer Resource Center. This online resource brings together content related to COVID-19 from across the AACR journals as soon as it is published—and it is free to access for the duration of the pandemic.

AACR Letter to Congress

AACR Calls on Congress to Take Immediate Action Against COVID-19 and Protect Patients with Cancer During the Pandemic

Research Articles

COVID-19 disruptions to endoscopic surveillance in Lynch syndrome

Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited

Cancer and COVID-19: On the Quest for Effective Vaccines

Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19

Examining COVID-19 Preventive Behaviors among Cancer Survivors in the United States: An Analysis of the COVID-19 Impact Survey

Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer

COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers

Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak

 

Perspectives & Commentaries

Is COVID-19–Induced Platelet Activation a Cause of Concern for Patients with Cancer?

How did we get a COVID-19 vaccine in less than one year?

At the Crossroads: COVID-19 and Immune Checkpoint Blockade for Cancer

Is COVID-19 - induced platelet activation a cause of concern for cancer patients?

Similarities in Risk for COVID-19 and Cancer Disparities

Don't Compromise Myeloma Care Due to COVID-19 Pandemic!

COVID-19, Cancer Care and Prevention

Disparities in Cancer Prevention in the COVID-19 Era

The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts

Cancer Research: The Lessons to Learn from COVID-19

COVID-19 Testing in Patients with Cancer: Does One Size Fit All?

Immune-Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era

The World of Clinical Trial Development Post-Covid-19: Lessons Learned from a Global Pandemic.

The Era of COVID-19 and the Rise of Science Collectivism in Cancer Research

The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action

BTK Inhibitors in Cancer Patients with COVID-19: “The Winner Will be the One Who Controls That Chaos” (Napoleon Bonaparte)

Adapting to a Pandemic — Conducting Oncology Trials during the SARS-CoV-2 Pandemic

 

Webinars

AACR Virtual Journal Club: Blood Cancer Discovery, Direct and Indirect Impact of COVID-19 on Multiple Myeloma Patients

 

News

COVID-19 Prolonged in Patients with Cancer

Cancer Immunotherapies Helped Shape COVID Vaccines

Survival Factors ID'd for Patients with Blood Cancer + COVID-19

Repurposing Cancer Drugs for COVID-19

Q&A: Solange Peters on COVID-19, Cancer Intersection; Immunotherapy Biomarkers

ICI Impact on COVID-19 Severity Modest at Best

COVID-19 Challenges Status Quo for Cancer Care

COVID-19 Delays Cancer Screenings

Registries Offer Insights on COVID-19–Cancer Connection

COVID-19 Hits Cancer Research Funding

Cytokine Storm Drugs Move from CAR T to COVID-19

Clinical Research Slows as COVID-19 Surges

IL6 Blockade Reverses Anemia in AML Mice

COVID-19 More Frequent, Severe in Cancer Patients

Cancer Care Goes Virtual in Response to COVID-19

Cancer Labs Pivot to Battle COVID-19

COVID-19 Challenges Basic Researchers

 

Reviews

Relevance of the Bruton Tyrosine Kinase (BTK) as a target for COVID-19 therapy

Harnessing CAR T Cell Insights to Develop Treatments for Hyperinflammatory Responses in COVID-19 patients

TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?

 


Publications Division
American Association for Cancer Research
615 Chestnut Street  |  17th Floor  |  Philadelphia, PA 19106-4404
Phone: (215) 440-9300  |  Fax: (215) 440-9354  |  E-mail:  pubs@aacr.org

  • Home
  • Alerts
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Article Collections

  • Focus Selections
  • "Best of" Collection

Info for:

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

AACR Journals

  • About AACR Journals
  • 3rd Party Permissions & Reprints
AACR logo

Copyright © 2021 by the American Association for Cancer Research.